Cresco Labs Inc. (FRA:6CQ)

Market Cap	317.45M +6.1%
Revenue (ttm)	563.90M -9.8%
Net Income	-44.48M
EPS	-0.13
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	76
Open	0.9815
Previous Close	0.9905
Day's Range	0.9815 - 0.9815
52-Week Range	0.3640 - 1.9000
Beta	n/a
RSI	41.16
Earnings Date	Mar 12, 2026

About Cresco Labs

Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand. The company offers canna...

• Industry: Pharmaceutical Preparations
• CEO: Charles Bachtell
• Employees: 2,900
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 6CQ

Financial Performance

In 2024, Cresco Labs's revenue was $715.76 million, a decrease of -5.33% compared to the previous year's $756.06 million. Losses were -$74.44 million, -57.59% less than in 2023.

Financial numbers in USD